These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 19883655)

  • 1. The mAKAPbeta scaffold regulates cardiac myocyte hypertrophy via recruitment of activated calcineurin.
    Li J; Negro A; Lopez J; Bauman AL; Henson E; Dodge-Kafka K; Kapiloff MS
    J Mol Cell Cardiol; 2010 Feb; 48(2):387-94. PubMed ID: 19883655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Muscle A-kinase-anchoring protein-β-bound calcineurin toggles active and repressive transcriptional complexes of myocyte enhancer factor 2D.
    Li J; Aponte Paris S; Thakur H; Kapiloff MS; Dodge-Kafka KL
    J Biol Chem; 2019 Feb; 294(7):2543-2554. PubMed ID: 30523159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A perinuclear calcium compartment regulates cardiac myocyte hypertrophy.
    Turcotte MG; Thakur H; Kapiloff MS; Dodge-Kafka KL
    J Mol Cell Cardiol; 2022 Nov; 172():26-40. PubMed ID: 35952391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The scaffold protein muscle A-kinase anchoring protein β orchestrates cardiac myocyte hypertrophic signaling required for the development of heart failure.
    Kritzer MD; Li J; Passariello CL; Gayanilo M; Thakur H; Dayan J; Dodge-Kafka K; Kapiloff MS
    Circ Heart Fail; 2014 Jul; 7(4):663-72. PubMed ID: 24812305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CaMKII negatively regulates calcineurin-NFAT signaling in cardiac myocytes.
    MacDonnell SM; Weisser-Thomas J; Kubo H; Hanscome M; Liu Q; Jaleel N; Berretta R; Chen X; Brown JH; Sabri AK; Molkentin JD; Houser SR
    Circ Res; 2009 Aug; 105(4):316-25. PubMed ID: 19608982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An adenylyl cyclase-mAKAPbeta signaling complex regulates cAMP levels in cardiac myocytes.
    Kapiloff MS; Piggott LA; Sadana R; Li J; Heredia LA; Henson E; Efendiev R; Dessauer CW
    J Biol Chem; 2009 Aug; 284(35):23540-6. PubMed ID: 19574217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PICOT attenuates cardiac hypertrophy by disrupting calcineurin-NFAT signaling.
    Jeong D; Kim JM; Cha H; Oh JG; Park J; Yun SH; Ju ES; Jeon ES; Hajjar RJ; Park WJ
    Circ Res; 2008 Mar; 102(6):711-9. PubMed ID: 18258855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mAKAP signalosome and cardiac myocyte hypertrophy.
    Bauman AL; Michel JJ; Henson E; Dodge-Kafka KL; Kapiloff MS
    IUBMB Life; 2007 Mar; 59(3):163-9. PubMed ID: 17487687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bidirectional regulation of HDAC5 by mAKAPβ signalosomes in cardiac myocytes.
    Dodge-Kafka KL; Gildart M; Li J; Thakur H; Kapiloff MS
    J Mol Cell Cardiol; 2018 May; 118():13-25. PubMed ID: 29522762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct and indirect interactions between calcineurin-NFAT and MEK1-extracellular signal-regulated kinase 1/2 signaling pathways regulate cardiac gene expression and cellular growth.
    Sanna B; Bueno OF; Dai YS; Wilkins BJ; Molkentin JD
    Mol Cell Biol; 2005 Feb; 25(3):865-78. PubMed ID: 15657416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcineurin Aβ-Specific Anchoring Confers Isoform-Specific Compartmentation and Function in Pathological Cardiac Myocyte Hypertrophy.
    Li X; Li J; Martinez EC; Froese A; Passariello CL; Henshaw K; Rusconi F; Li Y; Yu Q; Thakur H; Nikolaev VO; Kapiloff MS
    Circulation; 2020 Sep; 142(10):948-962. PubMed ID: 32611257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mAKAPβ signalosome: A potential target for cardiac hypertrophy.
    Golatkar V; Bhatt LK
    Drug Dev Res; 2023 Sep; 84(6):1072-1084. PubMed ID: 37203301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signalosome-Regulated Serum Response Factor Phosphorylation Determining Myocyte Growth in Width Versus Length as a Therapeutic Target for Heart Failure.
    Li J; Tan Y; Passariello CL; Martinez EC; Kritzer MD; Li X; Li X; Li Y; Yu Q; Ohgi K; Thakur H; MacArthur JW; Ivey JR; Woo YJ; Emter CA; Dodge-Kafka K; Rosenfeld MG; Kapiloff MS
    Circulation; 2020 Dec; 142(22):2138-2154. PubMed ID: 32933333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of calcineurin-NFAT hypertrophy signaling by cGMP-dependent protein kinase type I in cardiac myocytes.
    Fiedler B; Lohmann SM; Smolenski A; Linnemuller S; Pieske B; Schroder F; Molkentin JD; Drexler H; Wollert KC
    Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11363-8. PubMed ID: 12177418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of peroxisome proliferator-activated receptor gamma inhibits endothelin-1-induced cardiac hypertrophy via the calcineurin/NFAT signaling pathway.
    Bao Y; Li R; Jiang J; Cai B; Gao J; Le K; Zhang F; Chen S; Liu P
    Mol Cell Biochem; 2008 Oct; 317(1-2):189-96. PubMed ID: 18600431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mAKAP complex participates in the induction of cardiac myocyte hypertrophy by adrenergic receptor signaling.
    Pare GC; Bauman AL; McHenry M; Michel JJ; Dodge-Kafka KL; Kapiloff MS
    J Cell Sci; 2005 Dec; 118(Pt 23):5637-46. PubMed ID: 16306226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phospholipase C epsilon scaffolds to muscle-specific A kinase anchoring protein (mAKAPbeta) and integrates multiple hypertrophic stimuli in cardiac myocytes.
    Zhang L; Malik S; Kelley GG; Kapiloff MS; Smrcka AV
    J Biol Chem; 2011 Jul; 286(26):23012-21. PubMed ID: 21550986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. mAKAP-a master scaffold for cardiac remodeling.
    Passariello CL; Li J; Dodge-Kafka K; Kapiloff MS
    J Cardiovasc Pharmacol; 2015 Mar; 65(3):218-25. PubMed ID: 25551320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of MEF2 transcriptional activity by calcineurin/mAKAP complexes.
    Li J; Vargas MA; Kapiloff MS; Dodge-Kafka KL
    Exp Cell Res; 2013 Feb; 319(4):447-54. PubMed ID: 23261540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polydatin attenuates cardiac hypertrophy through modulation of cardiac Ca2+ handling and calcineurin-NFAT signaling pathway.
    Ding W; Dong M; Deng J; Yan D; Liu Y; Xu T; Liu J
    Am J Physiol Heart Circ Physiol; 2014 Sep; 307(5):H792-802. PubMed ID: 25015961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.